Navigation
Open Access
Article
Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?
Tariq I Mughal1,John M Goldman1
1
Division of Hematology and Oncology, University of Massachusetts Medical School, Worcester, MA 01655, USA. tmughal@freenet.co.uk
DOI: 10.2741/1791 Volume 11 Issue 1, pp.198-208
Published: 01 January 2006
(This article belongs to the Special Issue Tumor growth and metastasis: molecular signaling and therapy)
Abstract

Clinically chronic myeloid leukemia is a biphasic or triphasic disease that is usually diagnosed in the initial 'chronic', 'indolent' or 'stable' phase and then spontaneously evolves after some years into an advanced phase. This advanced phase can sometimes be subdivided into an earlier accelerated phase and a later blast phase or blast transformation--in about one-half of patients the chronic phase transforms unpredictably and abruptly to a blast phase, while in the other half of patients, the disease evolves somewhat more gradually, through an accelerated phase, which may last for months or years, before a blast phase ensues; this may have myeloblastic or lymphoblastic features. Although much is now known about the molecular biology of the disease, the molecular basis of disease progression is still obscure. The popular thinking has been that one or more probably a sequence of additional genetic events occurs in the BCR-ABL positive clone. When the critical combination of additional events is achieved, clinically definable transformation occurs. Here we review what is known of the mechanisms underlying the evolution of chronic myeloid leukemia from a chronic phase to a blast transformation.

Share and Cite
Tariq I Mughal, John M Goldman. Chronic myeloid leukemia: why does it evolve from chronic phase to blast transformation?. Frontiers in Bioscience-Landmark. 2006. 11(1); 198-208.